Forward-looking statements are subject to known and unknown risks, uncertainties and other factors, many of which are beyond the Company’s control, that could cause actual results or events to differ materially from those expressed or implied by such statements. These risks and uncertainties include, without limitation: the early-stage and experimental nature of the evaluation; the possibility that the parties may not agree on the Phase 2 Plan or may decide not to proceed to a later phase; the risk that funding, equipment, insurance, personnel, facilities or representative samples may not be available when required; delays in commissioning equipment or conducting laboratory work; the possibility that LH3M’s technology will not achieve the targeted purity, recovery, mass-balance, repeatability, scalability or economic performance; technical, analytical and scale-up uncertainties; sample loss, contamination or variability; intellectual-property, confidentiality or third-party infringement issues; regulatory, transport, safety and export-control requirements or delays; changes in helium-3 demand, availability, applications or pricing; the absence of an established transparent commodity market for helium-3; the parties’ inability to agree on a pilot or definitive commercial agreement; the possibility that any pilot or commercial system may not be technically or economically viable; and the other risks disclosed in the Company’s Annual Information Form dated February 3, 2026, for the year ended September 30, 2025, available under the Company’s profile on SEDAR+ at www.sedarplus.ca.